References
- Robins H., Kutz M., Tutsch K., Tigelaar C., Paul D., Longo W., d'Oleire F. Phase I clinical trial of melphalan (L‐PAM) and 41.8C whole body hyperthermia (WBH) in cancer patients. Journal of Clinical Oncology 1996, (in press)
- Robins H. I., Schmitt‐Tiggelaar C. L., Cohen J. D., Woods J. P., Heiss C., Gillis W., d'Oleire F. A new technological approach to heat whole body Hyperthermia. Cancer Letters 1994; 79: 137–145
- Robins H. I., Fennis W. H., Neville A. J., Shecterle L., Martin P. A., Grossman J., Davis T. E., Neville S., Gillis W., Rusey B. F. A non‐toxic system for 418C whole body hyperthermia: Results of a phase I study using a radiant heat device. Cancer Research 1985; 45: 3937–3944
- Robins H. I., Neville A. J., Cohen J. D. Whole body hyperthermia: biological, and clinical aspects. Springer‐Verlag, Berlin Heidelberg 1992
- Schecterle L. M., Kelly T., St. Cyr J. A. Letter: Safe and efficient extracorporeal method of inducing whole body hyperthermia. International Journal of Hyperthermia 1996; 12(4)569–571
- Wiedemann G. J., d'Oleire F., Knop E., Eleftheriadis S., Bucksy P., Feddersen S., Klouche M., Geisler J., Mentzel M., Schmucker P., Feyerabend T., Weiss C., Wagner T. Ifosfamide and Carboplatin combined with 418C whole‐body Hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Research 1994; 54: 5346–5350
- Wiedemann G. J., Katschinski D. M., Mentzel M., Wagner T., Robins H. I. Systematic hyperthermia and ICE chemotherapy for sarcoma. ASCO: Late breaking abstracts. Journal of Clinical Oncology 1996a; 14(5)1751
- Wiedemann G. J., Robins H. I., Gutsche S., Mentzel M., Deeken M., Katschinski D. M., Eleftheriadis S., Crahe R., Weiss C., Storer B., Wagner T. Ifosfamide, carboplatin and etoposide (ICE) combined with 41-8°C whole‐body hyperthermia in patients with refractory sarcoma. European Journal of Cancer 1996b; 32A(5)888–892